
President Donald Trump is reportedly moving to establish sweeping political control over the billions of dollars the federal government distributes annually for health and medical research.
According to multiple reports, Trump has directed Russ Vought, the director of the White House Office of Management and Budget (OMB), to draft an executive order that would fundamentally alter how the National Institutes of Health (NIH) awards its grants.
The proposed executive order would establish a new oversight board tasked with determining which specific research grants receive federal funding. The board would reportedly include Vought, NIH Director Jay Bhattacharya, and other political appointees, and would require unanimous approval for any grant to be awarded.
Bypassing Traditional Peer Review
If implemented, the directive would represent a massive centralization of power over the scientific community, giving the OMB director a direct and unprecedented role in determining how the health research agency distributes its congressionally appropriated funds.
Historically, the NIH relies on a rigorous, independent peer-review system, where panels of scientific and medical experts evaluate grant applications based on their scientific merit and potential to advance public health. By subjecting these decisions to a board of political appointees requiring unanimous consent, the administration would effectively bypass the traditional scientific vetting process.
The move aligns with the Trump administration’s broader efforts to reduce the influence of non-appointee experts across federal agencies and redirect government spending.
A History of Funding Clashes
The news of the drafted executive order follows mounting tensions between the White House and the scientific research community. The administration has previously faced intense criticism for attempting to freeze or cancel federal grants at numerous institutions. Recently, reports emerged of an Oval Office clash after the NIH director reportedly pushed back against the president’s requests to cut specific grants bound for Harvard University.
The Trump administration has consistently argued that increased scrutiny over federal grants is necessary to ensure the government is funding “solid science” and to realign the agency’s financial priorities.
Neither the White House, the Office of Management and Budget, nor the Department of Health and Human Services (which oversees the NIH) have issued formal comments regarding the timeline for the executive order’s rollout. However, the proposal is already drawing alarm from scientific advocates and researchers, who warn that injecting partisan politics into the grant process could severely stunt medical innovation and leave critical areas of disease research underfunded.

